未知生产厂商
Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia.
Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia.
Partial agonist of peroxisome proliferator-activated receptor (PPAR) gamma; results in improved glucose, lipid, and weight management.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
